IBDEI0HA ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8397,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,8397,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,8397,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,8398,0)
 ;;=871.4^^58^609^54
 ;;^UTILITY(U,$J,358.3,8398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8398,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,8398,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,8398,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,8399,0)
 ;;=242.90^^58^609^108
 ;;^UTILITY(U,$J,358.3,8399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8399,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,8399,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,8399,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,8400,0)
 ;;=135.^^58^609^101
 ;;^UTILITY(U,$J,358.3,8400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8400,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,8400,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,8400,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,8401,0)
 ;;=446.5^^58^609^107
 ;;^UTILITY(U,$J,358.3,8401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8401,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,8401,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,8401,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,8402,0)
 ;;=401.9^^58^609^49
 ;;^UTILITY(U,$J,358.3,8402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8402,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,8402,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,8402,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,8403,0)
 ;;=V72.0^^58^609^32
 ;;^UTILITY(U,$J,358.3,8403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8403,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,8403,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,8403,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,8404,0)
 ;;=V41.0^^58^609^91
 ;;^UTILITY(U,$J,358.3,8404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8404,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,8404,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,8404,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,8405,0)
 ;;=998.59^^58^609^89
 ;;^UTILITY(U,$J,358.3,8405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8405,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,8405,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,8405,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,8406,0)
 ;;=042.^^58^609^1
 ;;^UTILITY(U,$J,358.3,8406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8406,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,8406,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,8406,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,8407,0)
 ;;=053.29^^58^609^43
 ;;^UTILITY(U,$J,358.3,8407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8407,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,8407,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,8407,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,8408,0)
 ;;=054.40^^58^609^42
 ;;^UTILITY(U,$J,358.3,8408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8408,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,8408,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,8408,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,8409,0)
 ;;=190.1^^58^609^83
 ;;^UTILITY(U,$J,358.3,8409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8409,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,8409,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,8409,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,8410,0)
 ;;=190.2^^58^609^50
 ;;^UTILITY(U,$J,358.3,8410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8410,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,8410,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,8410,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,8411,0)
 ;;=190.7^^58^609^52
